Medicine and Dentistry
Tamoxifen
100%
Breast Cancer
84%
Neoplasm
45%
Endometrium Carcinoma
32%
Endometrium
29%
Krukenberg Tumor
27%
Disease
27%
Ovarian Tumor
26%
Endometrial Cancer
22%
Vaginal Ultrasonography
20%
Estrogen Receptor
19%
Color Doppler Flowmetry
18%
Postmenopause
18%
Progesterone Receptor
18%
Diagnosis
16%
Keratin 20
16%
Carcinoma
15%
Ovarian Cancer
15%
Bleeding
13%
Adenocarcinoma
12%
Malignant Neoplasm
12%
Reverse Transcription Polymerase Chain Reaction
11%
Flow Imaging
10%
Echography
10%
Salpingooophorectomy
9%
Pregnancy
9%
Gestational Age
9%
Abdominal Hysterectomy
9%
Serous Carcinoma
9%
Pelvis
9%
Endometrial Biopsy
9%
Laparotomy
9%
Peritoneum
8%
Cystadenoma
8%
Gestational Trophoblastic Disease
8%
Endometrial Stromal Sarcoma
8%
Paclitaxel
8%
Adjuvant Therapy
8%
Adenomyosis
8%
Circulating Tumor Cell
8%
Tumor Antigen
8%
Granulosa Cell Tumour
8%
Gestagen
8%
Biopsy
8%
Diethylstilbestrol
8%
Endometrial Polyp
7%
Pelvic Radiotherapy
7%
Lymph Node
7%
Cesarean Section
6%
Androgen
6%
Keyphrases
Breast Cancer Patients
83%
Postmenopausal Breast Cancer
76%
Tamoxifen Therapy
44%
Endometrial Pathology
33%
Tumor
33%
Endometrium
29%
Endometrial Carcinoma
22%
Estrogen Receptor
20%
Postmenopausal Women
18%
Endometrial Cancer
17%
Progesterone Receptor
17%
Chemotherapy
16%
Cytokeratin 20
16%
Breast Cancer
16%
Ovarian Tumor
15%
Colour Doppler Flow
15%
Endometrial Thickness
15%
Ovarian Cancer
13%
Epithelial Ovarian Cancer
13%
Carbohydrate Antigen 125 (CA125)
13%
Mezlocillin
12%
Management Aspects
12%
Adenomyosis
12%
Ovarian Volume
12%
Pathologic
10%
Gestational Age
10%
Pathological Findings
10%
Doppler Flow
10%
Clinical Aspects
10%
Gestational Trophoblastic Disease
10%
Postmenopausal Bleeding
10%
Gynecologic Oncology
10%
Salpingo-oophorectomy
10%
Transvaginal Ultrasonography
9%
Quantitative PCR
9%
Ovarian Carcinoma
9%
Endometrial Changes
9%
BRCA mutation
9%
Progesterone Receptor Expression
9%
Endometrial Sampling
9%
BRCA2
9%
Clinical Characteristics
8%
Peritoneum
8%
Postmenopausal Patients
8%
No Significant Difference
8%
Carcinoma
8%
Endometrial Polyp
8%
Abdominal Hysterectomy
8%
Estrogen Receptor Status
8%
Endometrial Biopsy
8%